JPH0150717B2 - - Google Patents
Info
- Publication number
- JPH0150717B2 JPH0150717B2 JP62024598A JP2459887A JPH0150717B2 JP H0150717 B2 JPH0150717 B2 JP H0150717B2 JP 62024598 A JP62024598 A JP 62024598A JP 2459887 A JP2459887 A JP 2459887A JP H0150717 B2 JPH0150717 B2 JP H0150717B2
- Authority
- JP
- Japan
- Prior art keywords
- androstene
- dione
- substance
- dihydroxy
- methanol
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- UDHAKZRCGHAPAZ-NFBMXZEVSA-N (6r,8r,9s,10r,13s,14r)-6,14-dihydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,15,16-decahydrocyclopenta[a]phenanthrene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@]4(O)[C@@H]3C[C@@H](O)C2=C1 UDHAKZRCGHAPAZ-NFBMXZEVSA-N 0.000 claims description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- 239000000126 substance Substances 0.000 description 14
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 8
- 102000014654 Aromatase Human genes 0.000 description 6
- 108010078554 Aromatase Proteins 0.000 description 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 6
- 239000002609 medium Substances 0.000 description 6
- 239000000758 substrate Substances 0.000 description 6
- 206010006187 Breast cancer Diseases 0.000 description 5
- 208000026310 Breast neoplasm Diseases 0.000 description 5
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 description 5
- 229960005471 androstenedione Drugs 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 4
- 238000000862 absorption spectrum Methods 0.000 description 4
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 description 4
- 238000006243 chemical reaction Methods 0.000 description 4
- 230000002401 inhibitory effect Effects 0.000 description 4
- 210000002826 placenta Anatomy 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 150000001443 androstenes Chemical class 0.000 description 3
- 230000004071 biological effect Effects 0.000 description 3
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 241000228417 Sarocladium strictum Species 0.000 description 2
- 239000002246 antineoplastic agent Substances 0.000 description 2
- 229940041181 antineoplastic drug Drugs 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 239000012156 elution solvent Substances 0.000 description 2
- 230000009422 growth inhibiting effect Effects 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 229960001603 tamoxifen Drugs 0.000 description 2
- IATKKATWPOVYCC-VMXHOPILSA-N (8s,9s,10r,13s,14s)-10,13-dimethyl-2,3,6,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthrene Chemical compound C1CC2=CCCC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CCC[C@@]1(C)CC2 IATKKATWPOVYCC-VMXHOPILSA-N 0.000 description 1
- 241001019659 Acremonium <Plectosphaerellaceae> Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 239000006145 Eagle's minimal essential medium Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 230000009982 effect on human Effects 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Priority Applications (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024598A JPS63192796A (ja) | 1987-02-06 | 1987-02-06 | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
| AT88901462T ATE78825T1 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| DE8888901462T DE3873200T2 (de) | 1987-02-06 | 1988-02-05 | Neue androst-4-en-3,17-dion-derivate und verfahren zur herstellung. |
| EP88901462A EP0300062B1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| PCT/JP1988/000114 WO1988005781A1 (en) | 1987-02-06 | 1988-02-05 | Novel androst-4-ene-3,17-dione derivatives and process for their preparation |
| US07/279,596 US4975368A (en) | 1987-02-06 | 1988-09-26 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
| US07/555,691 US5079377A (en) | 1987-02-06 | 1990-07-23 | Novel androst-4-ene-3,17-dione derivatives and method for preparing same |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP62024598A JPS63192796A (ja) | 1987-02-06 | 1987-02-06 | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS63192796A JPS63192796A (ja) | 1988-08-10 |
| JPH0150717B2 true JPH0150717B2 (cs) | 1989-10-31 |
Family
ID=12142587
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP62024598A Granted JPS63192796A (ja) | 1987-02-06 | 1987-02-06 | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオン |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPS63192796A (cs) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH06225793A (ja) * | 1992-11-27 | 1994-08-16 | Nippon Kayaku Co Ltd | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオンの新規製造法 |
-
1987
- 1987-02-06 JP JP62024598A patent/JPS63192796A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| JPS63192796A (ja) | 1988-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Baydoun et al. | Microbial transformation of anti-cancer steroid exemestane and cytotoxicity of its metabolites against cancer cell lines | |
| WO1991018003A1 (en) | Antitumor be-13793c derivative | |
| US5079377A (en) | Novel androst-4-ene-3,17-dione derivatives and method for preparing same | |
| CN107893090B (zh) | 土曲霉h768的发酵化合物在制备抗过敏药物中的应用 | |
| JPH0150717B2 (cs) | ||
| CN109985044B (zh) | 白桦醇及其衍生物在制备抗肿瘤药物中的应用 | |
| CN108992450B (zh) | 环黄芪醇衍生物在制备抗肝纤维化作用药物中的应用 | |
| CN115252624B (zh) | 一种白桦脂酮酸衍生物及其制备方法与应用 | |
| JPH0150716B2 (cs) | ||
| JPH0132236B2 (cs) | ||
| JP2689144B2 (ja) | ７〆，１１〆−ジヒドロキシーアンドロストー１，４−ジエン−３，１７−ジオン | |
| JP2622712B2 (ja) | ７α，１４α−ジヒドロキシ−アンドロスト−１，４−ジエン−３，１７−ジオン | |
| CN108707553B (zh) | 能够高效转化4ad特异性合成睾内酯酮和add的菌株及其应用 | |
| CN116284199A (zh) | 积雪草酸微生物转化衍生物及其制备方法与应用 | |
| JP2622700B2 (ja) | １５β‐ヒドロキシ‐１９‐ノル‐テストステロン | |
| Kupfer et al. | Metabolism in vitro of 19-nortestosterone in female rat liver homogenate | |
| JPH0369357B2 (cs) | ||
| Oohata et al. | A New Aromatase Inhibitor, FR901537 I. Taxonomy, Fermentation, Isolation, Physicochemical Characteristics and Biological Activities | |
| CN104447931B (zh) | 原人参三醇衍生物及其制备方法与应用 | |
| Klyne | The optical rotatory dispersion curves of trans-decalones and their polycyclic analogues | |
| JP3380667B2 (ja) | 新規生理活性物質ｐｆ１０９２ａ物質、ｐｆ１０９２ｂ物質及びｐｆ１０９２ｃ物質，それらの製造法並びにそれらを有効成分とする避妊剤及び制癌剤 | |
| CN118994072A (zh) | 红树林真菌来源的两种倍半萜类化合物及其制备方法和在抗炎药物中的应用 | |
| CN100582110C (zh) | 环己酮类饱和三环（桥环）化合物及其制备方法与用途 | |
| Sen et al. | Dedifferentiation and loss of thevetin in Thevetia peruviana callus | |
| JPH06225793A (ja) | ６β，１４α−ジヒドロキシ−４−アンドロステン−３，１７−ジオンの新規製造法 |